COMBINED USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID AND CYTARABINE (ARA-C) FOR THE TREATMENT OF LEUKEMIA

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP07811049.1

公开号：

EP2049109B1

申请日:

2007.08.02

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/